ID: ALA3274623

Max Phase: Preclinical

Molecular Formula: C14H18N2O

Molecular Weight: 230.31

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(=O)N1CC2(CCN(C)C2)c2ccccc21

Standard InChI:  InChI=1S/C14H18N2O/c1-11(17)16-10-14(7-8-15(2)9-14)12-5-3-4-6-13(12)16/h3-6H,7-10H2,1-2H3

Standard InChI Key:  NFKVONBKZSTPAZ-UHFFFAOYSA-N

Associated Targets(non-human)

Glycine receptor subunit alpha-1 65 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mus musculus 284745 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 230.31Molecular Weight (Monoisotopic): 230.1419AlogP: 1.63#Rotatable Bonds: 0
Polar Surface Area: 23.55Molecular Species: NEUTRALHBA: 2HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 8.32CX LogP: 0.81CX LogD: -0.16
Aromatic Rings: 1Heavy Atoms: 17QED Weighted: 0.68Np Likeness Score: -0.17

References

1. Hershenson FM, Prodan KA, Kochman RL, Bloss JL, Mackerer CR..  (1977)  Synthesis of beta-spiro[pyrrolidinoindolines], their binding to the glycine receptor, and in vivo biological acitivity.,  20  (11): [PMID:199727] [10.1021/jm00221a016]

Source